VG
Vikas Gambhir
About Vikas Gambhir
Data last updated:
Vikas Gambhir is a Director at Edura Pharmaceuticals Private Limited (since 2017) and Director at Edura Infracon Private Limited (since 2022). The companies operate in Pharma and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹6.38 Cr; the largest is Edura Pharmaceuticals Private Limited at ₹5.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Feb 2017 | 2010 | ₹5.55 Cr (FY 2025) | Active | |
| Director | 20 Jul 2022 | 2022 | ₹83 Lakh (FY 2025) | Active |
Board colleagues of Vikas Gambhir
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajan Vohra | 03122354 | Edura Pharmaceuticals Private Limited , Edura Infracon Private Limited | Director |
| Vikas | 03298037 | Edura Pharmaceuticals Private Limited , Edura Infracon Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Gambhir
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Gambhir
Vikas Gambhir currently holds 2 directorships: Edura Pharmaceuticals Private Limited (Director, since 13 Feb 2017, revenue ₹5.55 Cr (FY 2025)); Edura Infracon Private Limited (Director, since 20 Jul 2022, revenue ₹83 Lakh (FY 2025)).
Vikas Gambhir was first appointed on 13 Feb 2017 as Director at Edura Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jul 2022 at Edura Infracon Private Limited.
The 2 current companies of Vikas Gambhir that report revenue have a combined latest revenue of ₹6.38 Cr: Edura Pharmaceuticals Private Limited ₹5.55 Cr (FY 2025); Edura Infracon Private Limited ₹83 Lakh (FY 2025).
The current boards of Vikas Gambhir's companies include Rajan Vohra (Edura Pharmaceuticals Private Limited), Vikas (Edura Pharmaceuticals Private Limited).